Viewing Study NCT06453135


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-01-01 @ 10:58 PM
Study NCT ID: NCT06453135
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-13
First Post: 2024-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation
Sponsor: Tao Lin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module